×

or

Frontenac’s Sale of Excellarate to Encora

Frontenac’s Sale of Excellarate to Encora

JSA advised private equity fund Frontenac on the India leg of its 100% sale of Excellarate, including its Indian subsidiaries, to Encora.

Frontenac is a Chicago-based private equity firm, which focuses on investing in lower middle market buyout transactions. Excellarate is a global technology services and solutions company with over 20 years of domain expertise within health, insurance, financial and enterprise technologies. Encora is a global next-gen product engineering provider.

Core Transaction team involved Rishabh Gupta Partner; Akshath Mithal Associate; and Alisha Chawla Company Secretary.

About Lex Witness

Lex Witness Bureau

The LW Bureau is a seasoned mix of legal correspondents, authors and analysts who bring together a very well researched set of articles for your mighty readership. These articles are not necessarily the views of the Bureau itself but prove to be thought provoking and lead to discussions amongst all of us. Have an interesting read through.